What is the price target for ADAG stock?
13 analysts have analysed ADAG and the average price target is 11.57 USD. This implies a price increase of 204.52% is expected in the next year compared to the current price of 3.8.
NASDAQ:ADAG • US0053291078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADAGENE INC-ADR (ADAG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-06 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-24 | Guggenheim | Initiate | Buy |
| 2025-09-18 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Leerink Partners | Initiate | Outperform |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2022-12-07 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-09 | Morgan Stanley | Maintains | Overweight |
| 2022-02-01 | Morgan Stanley | Maintains | Overweight |
| 2022-01-06 | Morgan Stanley | Maintains | Overweight |
| 2021-07-16 | Morgan Stanley | Maintains | Overweight |
| 2021-06-25 | China Renaissance | Initiate | Buy |
| 2021-03-08 | Morgan Stanley | Initiate | Overweight |
| 2021-03-08 | Jefferies | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.29M -8.74% | 18.112M 94.96% | 103.2K -99.43% | 3.91M 3,688.76% | 4.59M 17.39% | 5.526M 20.39% | -100.00% | 4.794M | 41.748M 770.84% | 112.25M 168.88% | 184.01M 63.93% | ||
| EBITDA YoY % growth | -82.77M -16.20% | -22.74M 72.53% | -35.229M -54.92% | -31.873M 9.53% | -44.724M -40.32% | -58.654M -31.15% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -83.92M -15.98% | -23.72M 71.74% | -35.952M -51.57% | -33.84M 5.87% | -49.562M -46.46% | -60.441M -21.95% | -59.282M 1.92% | -95.577M -61.22% | -95.474M 0.11% | -26.095M 72.67% | 79.242M 403.67% | 160.99M 103.16% | |
| Operating Margin | -903.34% | -130.97% | -34,836.82% | -865.47% | -1,079.78% | -1,093.76% | N/A | N/A | -1,991.53% | -62.51% | 70.59% | 87.49% | |
| EPS YoY % growth | N/A -0.16% | N/A -5.06% | N/A 60.39% | -0.56 16.65% | -0.56 -0.36% | -0.59 -5.45% | -0.65 -9.77% | -0.49 24.61% | -0.09 81.25% | 0.56 711.11% | 1.22 118.18% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 | -0.19 | -0.10 | -0.09 76.46% | -0.08 46.67% | -0.09 52.63% |
| Revenue Q2Q % growth | -100.00% | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.588M | -12.138M 31.15% | -7.14M | -8.058M 48.64% | -8.568M 10.64% | -8.976M 26.05% |
All data in USD
13 analysts have analysed ADAG and the average price target is 11.57 USD. This implies a price increase of 204.52% is expected in the next year compared to the current price of 3.8.
ADAGENE INC-ADR (ADAG) will report earnings on 2026-08-10.
The consensus EPS estimate for the next earnings of ADAGENE INC-ADR (ADAG) is -0.15 USD and the consensus revenue estimate is 0 USD.
The consensus rating for ADAGENE INC-ADR (ADAG) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.